RecruitingPhase 4NCT06448195
Effects of Growth Hormone Therapy on Metabolic Function in Fatty Liver Post-Pituitary Adenoma Surgery
Studying Functioning pituitary adenoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Shanghai Zhongshan Hospital
- Principal Investigator
- Tao XieFudan University
- Intervention
- Polyethylene Glycol Somatropin (rDNA origin) Injection(drug)
- Enrollment
- 40 enrolled
- Eligibility
- 18-60 years · All sexes
- Timeline
- 2023 – 2025
Study locations (1)
- Shanghai Zhongshan Hospital, Shanghai, China
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06448195 on ClinicalTrials.govOther trials for Functioning pituitary adenoma
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE1NCT07456878Use of [18F] Fluoroethyl-L-tyrosine PET/MRI for Identifying Small Functional Pituitary AdenomasMayo Clinic
- RECRUITINGNCT07268183How Estrogen Fluctuations Before Diagnosis Affect the Size Prolactin-secreting TumorsHospices Civils de Lyon
- RECRUITINGPHASE4NCT07045935Metabolic Outcomes in Patients With Prolactinomas Under Dopamine Agonist TreatmentUniversity Hospital, Basel, Switzerland
- RECRUITINGNANCT06584123Molecular Pituitary Imaging Using 18F-FET PETUniversity of Cambridge
- ENROLLING BY INVITATIONNANCT06297473Physical Attendance Versus Telephone or Video Follow-up in Patients With Non-functioning Pituitary Tumors.Zealand University Hospital
- RECRUITINGNANCT06163261Individualized Physical Activity or Patients With Non Functioning Pituitary AdenomaVastra Gotaland Region
- RECRUITINGPHASE4NCT04107480PRolaCT - Three Prolactinoma RCTsLeiden University Medical Center
- ACTIVE NOT RECRUITINGPHASE3NCT02288962Dopamine Agonist Treatment of Non-functioning Pituitary AdenomasSt. Olavs Hospital